{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T16:04:23Z","timestamp":1765814663317,"version":"3.48.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"50","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,12]]},"abstract":"<jats:p>\n                    The precise relationship between adrenocortical carcinoma (ACC) and matrix metalloproteinases (MMP) remains unclear. In this 2-sample Mendelian randomization (MR) study, exposure data regarding serum MMP levels were obtained from genome-wide association studies that included 21,758 individuals across 13 cohorts of European ancestry. The outcome data related to ACC were sourced from the FinnGen research project. The inverse-variance weighting method was employed as the primary analytical approach and was further verified using a variety of statistical techniques, including MR-Egger, weighted median, weighted mode, Bayesian weighted Mendelian randomization, constrained maximum likelihood, contamination mixture method and debiased inverse-variance weighted method. A Steiger directionality test was applied to avoid a reverse causation association. To assess pleiotropy and heterogeneity, we conducted the MR-Egger intercept test, Cochran\n                    <jats:italic toggle=\"yes\">Q<\/jats:italic>\n                    test, and leave-one-out analyses. Using the IVW and Bonferroni-corrected approach, we observed that elevated serum levels of MMP-12 were associated with a reduced risk of ACC, with an odds ratio of 0.699 (95% confidence interval: 0.544\u20130.895;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.005). Sensitivity analyses indicated the absence of significant heterogeneity and pleiotropy within our study. Additionally, the Steiger directionality test did not detect a significant reverse causation effect. The causal relationship between MMP-12 levels and ACC could have significant implications for the diagnostic and therapeutic approaches employed in the management of ACC.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000046475","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T16:00:38Z","timestamp":1765814438000},"page":"e46475","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the causal relationship between matrix metalloproteinases and adrenocortical carcinoma: A Mendelian randomization study"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6347-1749","authenticated-orcid":false,"given":"Zheng","family":"Huang","sequence":"first","affiliation":[{"name":"Department of Urology, Shaoxing Second Hospital, Second Affiliated Hospital of Shaoxing University, Shaoxing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology, Zhejiang Province people\u2019s Hospital, Zhejiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20251215","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3390\/biomedicines13040894","article-title":"A senescence-associated gene signature for prognostic prediction and therapeutic targeting in adrenocortical carcinoma.","volume":"13","author":"Peng","year":"2025","journal-title":"Biomedicines"},{"key":"R2-20251215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/20406223211033103","article-title":"Adrenocortical carcinoma: current state of the art, ongoing controvers ies, and future directions in diagnosis and treatment.","volume":"12","author":"Shariq","year":"2021","journal-title":"Ther Adv Chronic Dis"},{"key":"R3-20251215","doi-asserted-by":"crossref","first-page":"102942","DOI":"10.1016\/j.ctrv.2025.102942","article-title":"Targeting pediatric adrenocortical carcinoma: molecular insights and emerging therapeutic strategies.","volume":"136","author":"Kuhlen","year":"2025","journal-title":"Cancer Treat Rev"},{"key":"R4-20251215","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1210\/jc.2018-00918","article-title":"Predictors of survival in adrenocortical carcinoma: an analysis from t he national cancer database.","volume":"103","author":"Tella","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"R5-20251215","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Netwo rk for the Study of Adrenal Tumors.","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"R6-20251215","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ucl.2025.01.009","article-title":"Update on adrenocortical carcinoma.","volume":"52","author":"Sarrafan-Chaharsoughi","year":"2025","journal-title":"Urol Clin North Am"},{"key":"R7-20251215","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3390\/cells8020158","article-title":"Behavior of metalloproteinases in adipose tissue, liver and arterial wall: an update of extracellular matrix remodeling.","volume":"8","author":"Berg","year":"2019","journal-title":"Cells"},{"key":"R8-20251215","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13062-025-00599-x","article-title":"Matrix metalloproteinase-9 is associated with tumor microenvironment remodeling of bladder cancer.","volume":"20","author":"Fang","year":"2025","journal-title":"Biol Direct"},{"key":"R9-20251215","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41419-020-03301-3","article-title":"Matrix metalloproteinase-10 protects against acute kidney injury by au gmenting epidermal growth factor receptor signaling.","volume":"12","author":"Hu","year":"2021","journal-title":"Cell Death Dis"},{"key":"R10-20251215","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41568-020-00329-7","article-title":"The matrix in cancer.","volume":"21","author":"Cox","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"R11-20251215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/03946320241304911","article-title":"Prognostic impact of matrix metalloproteinase 2 (MMP-2) and matrix met alloproteinase 9 (MMP-9) in Egyptian breast cancer patients.","volume":"38","author":"Fouad","year":"2024","journal-title":"Int J Immunopathol Pharmacol"},{"key":"R12-20251215","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.urolonc.2024.05.002","article-title":"Matrix metalloproteinases targeting in prostate cancer.","volume":"42","author":"Zhu","year":"2024","journal-title":"Urol Oncol"},{"key":"R13-20251215","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1186\/s12885-024-12489-y","article-title":"Basement membrane-related MMP14 predicts poor prognosis and response t o immunotherapy in bladder cancer.","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Cancer"},{"key":"R14-20251215","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1186\/s12876-024-03576-2","article-title":"Human blood metabolites and gastric cancer: a Mendelian randomization analysis.","volume":"24","author":"Zhang","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"R15-20251215","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.kint.2023.09.016","article-title":"Mendelian randomization for nephrologists.","volume":"104","author":"Dobrijevic","year":"2023","journal-title":"Kidney Int"},{"key":"R16-20251215","doi-asserted-by":"crossref","first-page":"6336","DOI":"10.1038\/s41467-020-20079-2","article-title":"Whole-genome sequencing analysis of the cardiometabolic proteome.","volume":"11","author":"Gilly","year":"2020","journal-title":"Nat Commun"},{"key":"R17-20251215","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/s42255-020-00287-2","article-title":"Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals.","volume":"2","author":"Folkersen","year":"2020","journal-title":"Nat Metab"},{"key":"R18-20251215","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population.","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"R19-20251215","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.21037\/tcr-23-2058","article-title":"Exploring the causal relationship between omega-3 and omega-6 fatty acids and kidney cancer: a Mendelian randomization study.","volume":"13","author":"Liu","year":"2024","journal-title":"Transl Cancer Res"},{"key":"R20-20251215","doi-asserted-by":"crossref","first-page":"151220","DOI":"10.1016\/j.ejcb.2022.151220","article-title":"Multiple roles for basement membrane proteins in cancer progression and EMT.","volume":"101","author":"Banerjee","year":"2022","journal-title":"Eur J Cell Biol"},{"key":"R21-20251215","first-page":"414","article-title":"Association of SDF1 and MMP12 with atherosclerosis and inflammation: clinical and experimental study.","volume":"11","author":"Marcos-Jubilar","year":"2021","journal-title":"Life (Basel)"},{"key":"R22-20251215","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s13402-021-00650-9","article-title":"Matrix metalloproteinase 12 is an independent prognostic factor predicting postoperative relapse of conventional renal cell carcinoma - a short report.","volume":"45","author":"Beres","year":"2022","journal-title":"Cell Oncol (Dordr)"},{"key":"R23-20251215","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.prp.2017.09.023","article-title":"The overexpression and predictive significance of MMP-12 in esophageal squamous cell carcinoma.","volume":"213","author":"Han","year":"2017","journal-title":"Pathol Res Pract"},{"key":"R24-20251215","first-page":"2238","article-title":"Matrix metalloproteinase 12 (MMP12) as an adverse prognostic biomarker of vascular invasion in hepatic cell carcinoma.","volume":"26","author":"Guo","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R25-20251215","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00262-020-02538-3","article-title":"Knocking out matrix metalloproteinase 12 causes the accumulation of M2 macrophages in intestinal tumor microenvironment of mice.","volume":"69","author":"Yang","year":"2020","journal-title":"Cancer Immunol Immunother"},{"key":"R26-20251215","doi-asserted-by":"crossref","first-page":"300060519825983","DOI":"10.1177\/0300060519825983","article-title":"The prognostic values of matrix metalloproteinases in ovarian cancer.","volume":"48","author":"Zeng","year":"2020","journal-title":"J Int Med Res"},{"key":"R27-20251215","doi-asserted-by":"crossref","first-page":"107750","DOI":"10.1016\/j.phrs.2025.107750","article-title":"MMP3 at the crossroads: linking molecular pathways to disease diagnosis and therapy.","volume":"216","author":"Jiang","year":"2025","journal-title":"Pharmacol Res"},{"key":"R28-20251215","doi-asserted-by":"crossref","first-page":"146","DOI":"10.3390\/ijms23010146","article-title":"Matrix metalloproteinases shape the tumor microenvironment in cancer progression.","volume":"23","author":"Niland","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R29-20251215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4048\/jbc.2020.23.e17","article-title":"Matrix metallopeptidase 3 polymorphisms: emerging genetic markers in human breast cancer metastasis.","volume":"23","author":"Suhaimi","year":"2020","journal-title":"J Breast Cancer"},{"key":"R30-20251215","doi-asserted-by":"crossref","first-page":"5661","DOI":"10.3390\/ijms26125661","article-title":"Plasma concentrations of matrilysins (MMP-7, MMP-26) and stromelysins (MMP-3, MMP-10) as diagnostic biomarkers in high-grade serous ovarian cancer patients.","volume":"26","author":"Ewa","year":"2025","journal-title":"Int J Mol Sci"},{"key":"R31-20251215","doi-asserted-by":"crossref","first-page":"1093990","DOI":"10.3389\/fimmu.2022.1093990","article-title":"The immunomodulatory role of matrix metalloproteinases in colitis-associated cancer.","volume":"13","author":"He","year":"2023","journal-title":"Front Immunol"},{"key":"R32-20251215","doi-asserted-by":"crossref","first-page":"12613","DOI":"10.3390\/ijerph191912613","article-title":"Higher content but not activity of stromelysin-2 (MMP-10) in comparison to stromelysin-1 (MMP-3) in human renal carcinoma.","volume":"19","author":"Kudelski","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"R33-20251215","doi-asserted-by":"crossref","first-page":"3683","DOI":"10.3390\/jcm10163683","article-title":"Enhanced expression but decreased specific activity of matrix metallop roteinase 10 (MMP-10) in comparison with matrix metalloproteinase 3 (MMP-3) in human urinary bladder carcinoma.","volume":"10","author":"Kudelski","year":"2021","journal-title":"J Clin Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046475","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T16:00:43Z","timestamp":1765814443000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000046475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":33,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000046475","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"2025-07-21","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-23","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}